Wells, Gregory J.,Diebold, James L.,Hudkins, Robert L.,Dandu, Reddeppareddy,Dunn, Derek,Chatterjee, Sankar,Zulli, Allison L.
申请号：
AU2007261464
公开号：
AU2007261464B2
申请日:
2007.06.19
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
